Apple Pharmaceuticals
Apple Pharmaceuticals
Andheri West, Mumbai, Maharashtra
SEND SMS
SEND EMAIL

Valpatasvir

Offering you a complete choice of products which include velasof, velpanat, myhep all and resof total.

Velasof

Velasof
  • Velasof
Get Best Quote
Approx. Price: Rs 13,990 / Bottle

Product Details:

Minimum Order Quantity3 Bottle
Strength/Dose (in mg or ml)400mg & 100mg
Pack Size28's Tablet
Product TypeAPI
BrandVelasof

Product Details:
Minimum Order Quantity3 Bottle
Strength/Dose (in mg or ml)400mg 100mg
Pack Size1 bottle
Product TypeFinish Product
Brandvelasof

 

Brand name:Velasof

Active Ingeridents:Velpatasvir Sofosbuvir

Company Name:Hetero

Package:28 tablets/bottle

Strength :Velpatasvir 100Mg Sofosbuvir 400Mg

 

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Side effects:

The most common adverse reactions with velpatasvir were headache and fatigue and when used with RBV in decompensated cirrhotics were fatigue, anemia, nausea, headache, insomnia, and diarrhea.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

storage:

Velasof Store below 30°C (86 ºF)

Request
Callback
Yes! I am interested

Velpanat

Velpanat
  • Velpanat
Get Best Quote
Approx. Price: Rs 25,000 / Bottle

Product Details:

Minimum Order Quantity3 Bottle
Strength/Dose (in mg or ml)400mg & 100mg
Pack Size28's Tablet

Product Details:
Minimum Order Quantity3 Bottle
Strength/Dose (in mg or ml)400mg 100mg
Pack Size1 Bottle
Product TypeFinish Product
BrandVelpanat

 

Brand name: Velpanat

Active Ingeridents:Velpatasvir    Sofosbuvir 

Company Name:Natco

Package:28 tablets/bottle

Strength :Velpatasvir 100Mg Sofosbuvir 400Mg

 

Indication:

Velpanat is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velpanat is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

Dosage and Administration:

Take Velpanat exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velpanat for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): Velpanat
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Side effects:

The most common adverse reactions with velpatasvir were headache and fatigue and when used with RBV in decompensated cirrhotics were fatigue, anemia, nausea, headache, insomnia, and diarrhea.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

storage:

Velpanat Store below 30°C (86 ºF)

Request
Callback
Yes! I am interested

Myhep ALL

Approx. Price: Rs 25,000 / Bottle

Product Details:

Minimum Order Quantity3 Bottle
Strength/Dose (in mg or ml)Velpatasvir 100Mg Sofosbuvir 400Mg
Pack Size28's Tablet
Product TypeAPI

Brand name: Myhep ALL

Active Ingeridents: Velpatasvir Sofosbuvir

Company Name: Mylan

Package: 28 tablets/bottle

Strength :Velpatasvir 100Mg Sofosbuvir 400Mg

 

Indication:

Myhep ALL is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Myhep ALL is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

Dosage and Administration:

Take Myhep ALL exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Myhep ALL for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): Myhep ALL
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Side effects:

The most common adverse reactions with velpatasvir were headache and fatigue and when used with RBV in decompensated cirrhotics were fatigue, anemia, nausea, headache, insomnia, and diarrhea.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

storage:

Myhep ALL Store below 30°C (86 ºF)

 

 

 



Additional Information:

  • Minimum Order Quantity: 3 Bottle
  • Request
    Callback
    Get Best Quote
    Yes! I am interested

    Resof Total

    Resof Total
    • Resof Total
    Get Best Quote
    Approx. Price: Rs 25,000 / Bottle

    Product Details:

    Minimum Order Quantity3 Bottle
    Strength/Dose (in mg or ml)Velpatasvir 100Mg Sofosbuvir 400Mg
    Pack Size28's Tablet
    Product TypeAPI

    Product Details: Minimum Order Quantity 3 Bottle Strength/Dose (in mg or ml) 400mg 100mg Pack Size 1 bottle Product Type Finish Product Brand Resof Total Brand name: Resof Total Active Ingeridents:Velpatasvir Sofosbuvir Company Name: Dr.Reddy’s Package: 28 tablets/bottle Strength :Velpatasvir 100Mg Sofosbuvir 400Mg Indication: Resof Total is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Resof Total is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity. Dosage and Administration: Take Resof Total exactly as your healthcare provider tells you to. Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Resof Total for 12 weeks. Patients with decompensated cirrhosis (Child-Pugh B or C): Resof Total plus weight-based ribavirin with food for 12 weeks Weight-based ribavirin dose. Less than 75 kg: 1000 mg/day PO divided BID ≥75 kg: 1200 mg/day PO divided BID Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite Side effects: The most common adverse reactions with velpatasvir were headache and fatigue and when used with RBV in decompensated cirrhotics were fatigue, anemia, nausea, headache, insomnia, and diarrhea. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. storage: Resof Total Store below 30°C (86 ºF)
    Request
    Callback
    Yes! I am interested

    Velasof

    Velasof
    • Velasof
    Get Best Quote
    Approx. Price: Rs 13,990 / Bottle

    Product Details:

    Minimum Order Quantity1 Bottle
    Strength/Dose (in mg or ml)Velpatasvir 100Mg Sofosbuvir 400Mg
    Pack Size28 tablets/bottle
    Product TypeFinish Product
    BrandVelasof

    Brand name: Velasof

    Active Ingeridents: Velpatasvir Sofosbuvir

    Company Name: Hetro

    Package: 28 tablets/bottle

    Strength :Velpatasvir 100Mg Sofosbuvir 400Mg

     

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

    Dosage and Administration:

    Take Velasof exactly as your healthcare provider tells you to.

    · Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velasof for 12 weeks.

    · Patients with decompensated cirrhosis (Child-Pugh B or C): Velasof

    · plus weight-based ribavirin with food for 12 weeks

    · Weight-based ribavirin dose.

    · Less than 75 kg: 1000 mg/day PO divided BID

    · ≥75 kg: 1200 mg/day PO divided BID

    · Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    · Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

     

    Side effects:

    The most common adverse reactions with velpatasvir were headache and fatigue and when used with RBV in decompensated cirrhotics were fatigue, anemia, nausea, headache, insomnia, and diarrhea.

    Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

    storage:

    Velasof Store below 30°C (86 ºF)

     

    Request
    Callback
    Yes! I am interested
    X
    Looking for “Valpatasvir”?


    Reach Us
    S. R. Manoharan (Proprietor)
    Flat No. 304, A Wing, Shiva Shakti CHS Limited J P Road, Near Apna Bazar, Andheri West
    Mumbai- 400058, Maharashtra, India


    Call Us

    Send E-mail

    Send SMS